A newly-established Lipitor lawsuit litigation is making significant progress just three months after its creation in the District of South Carolina, with a recent agreement on forms related to the exchange of information between parties.
A court ruling on May 2nd indicates that use of a form Plaintiff’s Fact Sheet (PFS) has been agreed upon in the proceeding, which includes claims filed by women who similarly allege new-onset diabetes caused by the cholesterol drug. As of May 9, plaintiffs have been directed to submit medical records, authorizations, and other required documents with the fact sheet by June 2. Following its establishment in February, court records from April 15th show 464 claims filed in the U.S. District Court, District of South Carolina on behalf of plaintiffs who allegedly developed Type 2 diabetes after taking the cholesterol-lowering statin.
A Conditional Transfer Order on May 9 indicates that this number may have further increased since then, with more than 600 cases now been filed in the litigation.
With the steady filing of Lipitor diabetes lawsuits comes the creation of a discovery plan and process for selecting the litigation’s first cases for trial. These hearings are referred to as “bellwether trials” and will hopefully predict how juries will rule in similar action against the drug’s manufacturer, Pfizer Inc. Plaintiffs in cases over Lipitor similarly accuse the company of failing to provide adequate warning about the statin’s alleged association with Type 2 diabetes, even after a mandate from the U.S. Food and Drug Administration (FDA) ordered the company to adjust its labeling to include the risk in February 2012. Plaintiffs further allege that the revised alert was insufficient, and that Pfizer withheld Lipitor safety information is it was becoming one of the most widely-used cholesterol medications in the U.S.
Starting with cases filed in this month, the Court has ordered that all plaintiffs submit their fact sheets within 30 days of their transfer to the South Carolina MDL.
Call our Firm today to learn about the rising Lipitor lawsuit litigation in the U.S. Our attorneys can be reached at .